AnteoTech Ltd (ASX:ADO) Reports 130% Sales Growth in Life Sciences Unit
AnteoTech Ltd (ASX:ADO) reports a 130% sales increase in its Life Sciences unit and secures a significant order from the Serum Institute of India.
Tag: Industry-Specific News
dorsaVi Ltd (ASX:DVL) Secures Exclusive Worldwide Licence for Advanced RRAM Technology
dorsaVi Ltd (ASX:DVL) secures an exclusive worldwide licence for advanced RRAM technology, enhancing its wearable sensors and expanding market opportunities.
Bioxyne Limited (ASX:BXN) Upgrades FY2025 Revenue Guidance
Bioxyne Limited (ASX:BXN) upgrades its FY2025 revenue guidance to $28m, driven by significant growth in Australian operations and European expansion.
HITIQ Limited (ASX:HIQ) Announces Exclusive Global Agreement with Shock Doctor
HITIQ Limited (ASX:HIQ) forms an exclusive global partnership with Shock Doctor to enhance concussion management through the PROTEQT instrumented mouthguard.
Geopacific Resources Limited (ASX:GPR) Announces High-Grade Auger Sampling Results
Geopacific Resources (ASX:GPR) reports significant high-grade gold results, extending surface mineralisation at its Woodlark Project.
Peninsula Energy (ASX:PEN) Settles Samuel EPC Claims and Updates Lance Project
Peninsula Energy (ASX:PEN) settles Samuel EPC claims and provides updates on the Lance Project and key personnel changes.
Larvotto Resources (ASX:LRV) Reports High-Grade Gold and Antimony Drill Results
Larvotto Resources (ASX:LRV) announces high-grade gold and antimony results from its Eleanora-Garibaldi and Golden Gate drilling programs.
Nova Minerals (ASX:NVA) Commences Antimony-Gold Drilling at Stibium
Nova Minerals (ASX:NVA) begins a 3,000m antimony-gold drilling program at Stibium, aiming to establish maiden resource estimates.
Service Stream Limited (ASX:SSM) Secures Further nbn Fibre Upgrade Works
Service Stream Limited (ASX:SSM) secures a $440 million agreement with NBN Co to support further fibre upgrades.
Noxopharm Limited (ASX:NOX) Announces Positive Sofra™ Data from BioRay Collaboration
Noxopharm Limited (ASX:NOX) announces positive Sofra™ data from BioRay collaboration, validating its anti-inflammatory potential.